ArriVent BioPharma, Inc. AVBP Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s investment purchases?
- ArriVent BioPharma, Inc. (AVBP) reported investment purchases of $64.38M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s investment purchases changed year-over-year?
- ArriVent BioPharma, Inc.'s investment purchases increased by 555.8% year-over-year, from $9.82M to $64.38M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s investment purchases?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s investment purchases has grown at a 230.4% compound annual growth rate (CAGR), from $25M to $272.93M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.